Venture
Modernizing Medicine, Inc.
Latest Form D 2022-02-22- CIK 1491798
- State FL
- Other
- 8 Form D offerings since 2010-05-20
- Total sold
- $341M
- across 8 offerings
- Rounds
- 8
- Form D offerings since 2010-05-20
- Latest round
- $53.4M
- 2022-02-22 · 021-434386
- Investors
- 38
- on the latest round
Connected
named in its Form D filingsOfferings · since 2010-05-208 Form D offeringsExemptions506(b) · 506People · Item 3Daniel Cane + 11 moreInvestors · dashboardInferred investors
Modernizing Medicine, Inc.CIK 1491798
Round timeline
amount sold · by first filed2022-02-22 · $53.4M
- 2010-05-20$425K021-142312
- 2011-03-01$7.1M021-156000
- 2012-07-17$6.6M021-181350
- 2013-08-20$14M021-201580
- 2014-11-12$15.6M021-228159
- 2015-09-15$38M021-247627
- 2017-05-22$206M021-287220
- 2022-02-22$53.4M021-434386
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($206M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-434386 | First filed2022-02-22 | Latest2022-02-22 | Sought$53.4M | Sold$53.4M | Investors38 | Exemptions506(b) |
| 021-287220 | First filed2017-05-22 | Latest2017-05-22 | Sought$231M | Sold$206M | Investors6 | Exemptions506(b) |
| 021-247627 | First filed2015-09-15 | Latest2015-09-15 | Sought$38M | Sold$38M | Investors7 | Exemptions506(b) |
| 021-228159 | First filed2014-11-12 | Latest2014-11-12 | Sought$20M | Sold$15.6M | Investors60 | Exemptions506(b) |
| 021-201580 | First filed2013-08-20 | Latest2013-08-20 | Sought$14M | Sold$14M | Investors4 | Exemptions506 |
| 021-181350 | First filed2012-07-17 | Latest2012-07-17 | Sought$8.2M | Sold$6.6M | Investors67 | Exemptions506 |
| 021-156000 | First filed2011-03-01 | Latest2011-03-01 | SoughtIndefinite | Sold$7.1M | Investors47 | Exemptions506 |
| 021-142312 | First filed2010-05-20 | Latest2010-05-20 | SoughtIndefinite | Sold$425K | Investors10 | Exemptions506 |
Who backs Modernizing Medicine, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2022-02-22
| Name | Relationship |
|---|---|
| Daniel Cane | RelationshipExecutive Officer, Director |
| Michael Sherling | RelationshipExecutive Officer, Director |
| Mark Fleisher | RelationshipExecutive Officer |
| Barry Mosheim | RelationshipDirector |
| Amr Kronfol | RelationshipDirector |
| Andrew Park | RelationshipDirector |
| Jean Bua | RelationshipDirector |
| Phillip Pead | RelationshipDirector |
| Gina Loften | RelationshipDirector |
| Gary Steele | RelationshipDirector |
| Joseph Harpaz | RelationshipExecutive Officer |
| Michelle Scheer | RelationshipExecutive Officer |
Facts
As its latest Form D states them
- Industry
- Other
- State
- Florida (FL)
- Exemptions
- Rule 506(b); Rule 506
- First filed
- 2010-05-20
- Latest filing
- 2022-02-22
Who backs Modernizing Medicine, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗